CEBIOTEX

Quick facts

Phase 2 pipeline

• CEB-01 · Diabetes
  CEB-01 is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• CEB-01 membrane loaded with SN-38

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CEBIOTEX portfolio CI brief
• CEBIOTEX pipeline updates RSS